Brief: Orgenesis Board Says Financial Statements For Qtrs Ended March 31, 2023, June 30, 2023, Sept 30, 2023, To No Longer Be Relied Upon
15/04/2024 23:22
April 15 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS- BOARD DETERMINED CO'S FINANCIAL STATEMENTS FOR
QTRS
ENDED MARCH 31, 2023, JUNE 30, 2023, SEPT 30, 2023, SHOULD NO
LONGER BE RELIED UPON
Source text for Eikon: ID:n0001493152-24-014646
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules